WellSpan Health's venture capital strategy focuses on making targeted investments in early-stage companies that support their digital transformation and innovation initiatives. They prioritize healthcare innovation, digital health, population health, and community health, often acting as an "alpha customer" to co-develop and scale AI technologies aimed at improving care quality, operational efficiency, and workforce capacity.
100% of their portfolio is in Healthcare. Their most common stage is series-c (100% of deals).
Portfolio
1
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
 Hippocratic AI | Series C | $53M | Mar 2024 |
Top Co-Investors
Last updated: 4 May 2026